10-Q: Hercules Capital Reports First Quarter 2024 Results, Portfolio Shows Strong Growth

Sentiment:

Quarterly Report


Hercules Capital's first quarter 2024 results show a significant increase in investment income and a growing portfolio, despite some unrealized depreciation.

Capital raiseThe company issued and sold 3.7 million shares of its common stock through its equity distribution agreement, receiving net proceeds of approximately $66.4 million.As of March 31, 2024, approximately 13.6 million shares remain available for issuance and sale under the current equity distribution agreement.
Better than expectedThe company's net investment income increased by approximately 21% year-over-year.The company's total assets increased by approximately 8% since the end of 2023.The company's net asset value per share increased by approximately 2% since the end of 2023.

Summary

  • Hercules Capital reported a net increase in net assets resulting from operations of $91.0 million for the first quarter of 2024.
  • The company's total investment income reached $121.6 million, up from $105.1 million in the same period last year.
  • Net investment income was $79.2 million, compared to $65.5 million in the first quarter of 2023.
  • The company experienced a net realized gain of $8.2 million and a net change in unrealized appreciation of $3.6 million.
  • The company's total assets increased to $3.7 billion, up from $3.4 billion at the end of 2023.
  • The company's total debt outstanding was $1.8 billion as of March 31, 2024.
  • The company's net asset value per share increased to $11.63 from $11.43 at the end of 2023.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong growth in investment income and net asset value, but also acknowledges some risks and unrealized depreciation. The company's performance is solid, but the macroeconomic environment and potential for credit losses temper the overall sentiment.

Positives

  • The company's net investment income increased by approximately 21% year-over-year.
  • The company's total assets increased by approximately 8% since the end of 2023.
  • The company's net asset value per share increased by approximately 2% since the end of 2023.
  • The company has a significant amount of unfunded commitments, which represents potential for future growth.

Negatives

  • The company experienced a net change in unrealized depreciation of $3.6 million, indicating some portfolio investments decreased in value.
  • The company's operating expenses increased to $42.4 million, up from $39.6 million in the same period last year.
  • The company's cash and cash equivalents decreased to $50.2 million from $98.9 million at the end of 2023.

Risks

  • The company's portfolio is subject to market risks, including changes in interest rates and credit quality.
  • The company's portfolio is concentrated in technology, life sciences, and sustainable and renewable technology industries, which may be subject to volatility.
  • The company's portfolio companies are primarily privately held, which may make valuation more difficult.
  • The company's portfolio companies may be impacted by macroeconomic events, including inflation, interest rate volatility, and potential recession.
  • The company's debt investments are subject to credit risk, and some may be placed on non-accrual status.

Future Outlook

The company intends to continue to operate in order to generate cash flows from operations, including income earned from investments in our portfolio companies. Our primary use of funds will be investments in portfolio companies and cash distributions to holders of our common stock.

Management Comments

  • Management believes they and their portfolio are well positioned to manage the current environment.
  • Management will continue to monitor macroeconomic market developments and their related impact to their business.

Industry Context

The company operates in the specialty finance sector, focusing on high-growth, innovative companies in technology, life sciences, and sustainable and renewable technology industries. This sector is characterized by high margins, high growth rates, consolidation and product and market extension opportunities. The company's performance is influenced by the overall health of the venture capital market and the success of its portfolio companies.

Comparison to Industry Standards

  • Hercules Capital's core yield on debt investments was 14.0% for the three months ended March 31, 2024, which is within the range of other BDCs focused on venture debt.
  • The company's net asset value per share increased to $11.63, which is a positive indicator compared to some BDCs that have experienced NAV declines.
  • The company's total return of 13.6% for the three months ended March 31, 2024, is a strong performance compared to the average BDC total return.
  • The company's portfolio is concentrated in technology and life sciences, which is a common strategy for BDCs focused on venture debt, but may be more volatile than BDCs with more diversified portfolios.
  • The company's use of floating rate debt investments is a common strategy for BDCs to benefit from rising interest rates, but may also expose them to interest rate risk.

Related Party Transactions

  • The Adviser Subsidiary has entered into investment management agreements with its privately offered Adviser Funds, and it receives management fees based on the assets under management of the Adviser Funds.
  • The Company has a shared services agreement with the Adviser Subsidiary, through which the Adviser Subsidiary has access to the Company's human capital resources and other resources and infrastructure.
  • The Company may from time-to-time make investments alongside the Adviser Funds or assign a portion of investments to the Adviser Funds in accordance with the Companys allocation policy.

Stakeholder Impact

  • Shareholders benefit from the increase in net asset value per share and the continued payment of dividends.
  • Employees benefit from the company's continued growth and profitability.
  • Portfolio companies benefit from the company's continued investment and support.
  • Creditors benefit from the company's strong financial position and ability to repay its obligations.

Next Steps

  • The company will continue to monitor macroeconomic market developments and their related impact to their business.
  • The company will continue to evaluate its overall liquidity position and take proactive steps to maintain the appropriate liquidity position based upon the current circumstances.

Key Dates

DateDescription
2018-09-24Date of issuance of the 2033 Notes.
2020-02-05Date of issuance of the February 2025 Notes.
2020-06-03Date of issuance of the June 2025 Notes.
2020-10-27Date Hercules Capital IV, L.P. received its license to operate as a Small Business Investment Company (SBIC).
2020-11-04Date of issuance of the March 2026 A Notes.
2021-03-04Date of issuance of the March 2026 B Notes.
2021-09-16Date of issuance of the September 2026 Notes.
2022-01-20Date of issuance of the January 2027 Notes.
2022-06-22Date of issuance of the 2031 Asset-Backed Notes.
2023-05-05Date of the 2023 Equity Distribution Agreement.
2024-03-06Date of declaration of the base and supplemental cash distributions.
2024-03-31End of the reporting period.
2024-04-25Date of declaration of the supplemental cash distribution.
2024-05-21Date of payment of the base and supplemental cash distributions.

Keywords

Business Development Company, BDC, Venture Capital, Debt Financing, Technology, Life Sciences, Sustainable Technology, Renewable Technology, Structured Debt, Private Equity, Investment Income, Net Asset Value, Unfunded Commitments, Credit Risk, Interest Rate Risk

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.